entertainment -WSS

entertainment

author：hotspot 2025-10-02 10:45:40 - browse：4

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Immune cells and nerve overgrowth may explain recurring UTI pain

WSS

Longer MASH drug regimen improved liver, Akero study finds

House passes resolution saying Israel isn't a 'racist or apartheid state'

Robert Kennedy Jr.'s presidential campaign attracts GOP

He's 19 months old and has one of the world’s rarest diseases

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

The public health thinking behind the CDC’s new Covid guidance

hotspot

entertainment

focus

Peter Hotez and the public health issue of online harassment

Microsoft's Peter Lee: Generative AI could help doctors be more human

Alkermes shareholders re

Why Talkspace is targeting Medicare, a tricky market

Trump demands the U.S. pay no more for drugs than other countries … again

More hospitals are billing patients as online messages surge

DIEP, the 'gold standard' of breast reconstruction, is under threat

He's 19 months old and has one of the world’s rarest diseases

Guidelines to prevent youth baseball injuries need more muscle

Families look for replacement for GSK asthma drug Flovent

hotspot

Readout Newsletter: BridgeBio, Akero, and human embryo models

House passes resolution saying Israel isn't a 'racist or apartheid state'

Stem cell biologist probes earliest stages of human development

Harvard's David Sinclair gets blowback over aging

Lack of health data on LGBTQ+ people has serious consequences

Manchin plays down potential 3rd

hotspot

hotspot

leisure time

hotspot